Shire Shares Rise on Product Outlook

Shire Shares Rise on Product Outlook - CNNMoney.com

Shire Shares Rise on Product Outlook
CNNMoney.com - 19 hours ago
Shire will lose patent protection on its ADHD drug Adderall XR next year, but increasing sales of Vyvanse, the bowel disorder drug Lialda and the Hunter …
Auxilium Shares Rise on Study Outlook CNNMoney.com
Movers Roundup: Auxilium, China Unicom Houston Chronicle
all 19 news articles

April 3rd, 2008
Adderall

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: